Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 13Gynecologic 8Thoracic 4Sarcoma 2Genitourinary 2Endocrine 2Breast 2Other solid neoplasm 1NET 1Head & Neck 1Dermatologic 1

Conditions

Neuroendocrine Tumors 69Gastro-enteropancreatic neuroendocrine tumor 8Pheochromocytoma 7Carcinoma, Neuroendocrine 7Carcinoid Tumor 7Adenoma, Islet Cell 7Paraganglioma 6Neoplasms 5Melanoma 5Breast Neoplasms 5Thyroid Neoplasms 4Sarcoma 4Pancreatic Neoplasms 4Neuroblastoma 4Neoplasm Metastasis 4Carcinoma 4Serotonin Syndrome 3Prostatic Neoplasms 3Ovarian Neoplasms 3Neuroectodermal Tumors, Primitive 3Mesothelioma 3Meningioma 3Liver Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Merkel Cell 3Carcinoma, Hepatocellular 3Anus Neoplasms 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Appendiceal Neoplasms × NET × 90 days × Clear all
NCT06263088 2026-05-22

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Case Comprehensive Cancer Center

Phase NA Recruiting
200 enrolled
EndocrineGastrointestinalNET

Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡